daniel henrion
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Anti-Cancer Drugs
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Antwerp
Antwerp, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs
Centre for Clinical Research, Faculty of Medicine, The University of Queensland
Herston, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
United States Food and Drug Administration
Silver Spring, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Institute for Research in Immunology and Cancer, Montreal university
Montreal, Canada
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
China Medical University (Taiwan)
Taichung, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
Augusta University
Augusta, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Shanghai Jiao Tong University
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
China Medical University Hospital
Taichung, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
Guangdong Pharmaceutical University
Guangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Dalian University of Technology
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
South China University of Technology
Guangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Department of Medical Research, Taipei Medical University Hospital
Taipei, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
Taipei Medical University
Taipei, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs